Reporting of adverse events ONLY

Patients should always seek the advice of a doctor or pharmacist in case of adverse events.

If you wish to report an adverse event to ELC Group s.r.o., please find the contact information below:

+420 224 910 672

(from 09.00-17.30 CET)

+420 226 251 459

(non-stop 24/7)

To contact us about any other issue please call:

+420 22 491 0000or our regional offices.

Hlášení nežádoucích príhod

Pacienti by meli vždy požádat o radu svého lékare nebo lékárníka v prípade výskytu nežádoucích príhod.

Pokud chcete nahlásit nežádoucí príhodu spolecnosti ELC Group s r.o., prosím využijte kontaktních údaju níže:

+420 224 910 672

(09.00-17.30 CET)

+420 226 251 459

(non-stop 24/7)

Pro záležitosti, které se netýkaji farmakovigilance, kontaktujte prosím recepci:

+420 22 491 0000 nebo naše další pobočky.

Quality in Pharmacovigilance

Date: 19.11.2020

Time: 10:00 CET

Price: Free of Charge


On Thursday 19th November 2020, at 10:00 CET (Central European Time, GMT+2), ELC will be hosting a webinar providing an overview on the Quality in Pharmacovigilance

The presenters will be Marco Rubinstein, CEO of ELC Group and Mr. Pinkal Vithlani, senior manager of Pharmacovigilance Quality Assurance.

We are going to take you through the following topics:

  1. Introduction to quality in Pharmacovigilance
  2. Measuring quality of pharmacovigilance system
  3. Components of quality management system
  4. Findings related to quality system
  5. Q&As

Please note that the number of participants is limited.

To register, click here